{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:04:46Z","timestamp":1784862286530,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,8,15]],"date-time":"2008-08-15T00:00:00Z","timestamp":1218758400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell Mol Neurobiol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10571-008-9299-5","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T16:44:08Z","timestamp":1218732248000},"page":"81-85","source":"Crossref","is-referenced-by-count":12,"title":["Genetic Analysis of Interleukin-1A C(-889)T Polymorphism with Alzheimer Disease"],"prefix":"10.1007","volume":"29","author":[{"given":"Ji-liang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-xiang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-xi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-shan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-xiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-dan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-jun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,8,15]]},"reference":[{"issue":"3","key":"9299_CR1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","volume":"21","author":"H Akiyama","year":"2000","unstructured":"Akiyama H et al (2000) Inflammation and Alzheimer\u2019s disease. Neurobiol Aging 21(3):383\u2013421","journal-title":"Neurobiol Aging"},{"key":"9299_CR2","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington DC","edition":"4"},{"issue":"1","key":"9299_CR3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1212\/WNL.48.1.139","volume":"48","author":"D Blacker","year":"1997","unstructured":"Blacker D et al (1997) ApoE\u20134 and age of onset of Alzheimer\u2019s disease: the NIMH genetics initiative. Neurology 48(1):139\u2013147","journal-title":"Neurology"},{"issue":"1","key":"9299_CR4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1096\/fasebj.13.1.63","volume":"13","author":"I Blasko","year":"1999","unstructured":"Blasko I et al (1999) TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J 13(1):63\u201368","journal-title":"FASEB J"},{"issue":"3","key":"9299_CR5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/302553","volume":"65","author":"D Campion","year":"1999","unstructured":"Campion D et al (1999) Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrum. Am J Hum Genet 65(3):664\u2013670","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9299_CR6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1212\/WNL.55.4.480","volume":"55","author":"Y Du","year":"2000","unstructured":"Du Y et al (2000) Association of an interleukin 1 alpha polymorphism with Alzheimer\u2019s disease. Neurology 55(4):480\u2013483","journal-title":"Neurology"},{"issue":"1","key":"9299_CR7","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/ana.410390110","volume":"39","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla T et al (1996) Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer\u2019s disease. Ann Neurol 39(1):62\u201370","journal-title":"Ann Neurol"},{"issue":"10","key":"9299_CR8","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.58.10.1566","volume":"58","author":"EK Green","year":"2002","unstructured":"Green EK et al (2002) Are interleukin-1 gene polymorphisms risk factors or disease modifiers in AD? Neurology 58(10):1566\u20131568","journal-title":"Neurology"},{"issue":"19","key":"9299_CR9","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1073\/pnas.86.19.7611","volume":"86","author":"WS Griffin","year":"1989","unstructured":"Griffin WS et al (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci USA 86(19):7611\u20137615","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9299_CR10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/1531-8249(200003)47:3<361::AID-ANA12>3.0.CO;2-N","volume":"47","author":"LM Grimaldi","year":"2000","unstructured":"Grimaldi LM et al (2000) Association of early-onset Alzheimer\u2019s disease with an interleukin-1_ gene polymorphism. Ann Neurol 47(3):361\u2013365","journal-title":"Ann Neurol"},{"issue":"10","key":"9299_CR11","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/jnnp.2003.030866","volume":"75","author":"A Hayes","year":"2004","unstructured":"Hayes A et al (2004) A polymorphic variation in the interleukin 1A gene increases brain microglial cell activity in Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 75(10):1475\u20131477","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"9299_CR12","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.10196","volume":"51","author":"R Hedley","year":"2002","unstructured":"Hedley R et al (2002) Association of interleukin-1 polymorphisms with Alzheimer\u2019s disease in Australia. Ann Neurol 51(6):795\u2013797","journal-title":"Ann Neurol"},{"issue":"9","key":"9299_CR13","first-page":"757","volume":"29","author":"XF Hu","year":"2002","unstructured":"Hu XF et al (2002) Association between apolipoprotein E gene polymorphism and the patients with persistent vegetative state in the Chinese. Yi Chuan Xue Bao 29(9):757\u2013760","journal-title":"Yi Chuan Xue Bao"},{"issue":"4","key":"9299_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000099471","volume":"23","author":"J Infante","year":"2007","unstructured":"Infante J et al (2007) Interaction between poly(ADP-ribose) polymerase 1 and interleukin 1A genes is associated with Alzheimer\u2019s disease risk. Dement Geriatr Cogn Disord 23(4):215\u2013218","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"6","key":"9299_CR15","first-page":"817","volume":"49","author":"CS Ki","year":"2001","unstructured":"Ki CS et al (2001) Lack of association of the interleukin-1-alpha gene polymorphism with Alzheimer\u2019s disease in a Korean population. Ann Neurol 49(6):817\u2013818","journal-title":"Ann Neurol"},{"issue":"2","key":"9299_CR16","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1097\/00002093-200304000-00007","volume":"17","author":"YM Kuo","year":"2003","unstructured":"Kuo YM et al (2003) Lack of association between interleukin-1alpha polymorphism and Alzheimer disease or vascular dementia. Alzheimer Dis Assoc Disord 17(2):94\u201397","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"9","key":"9299_CR17","first-page":"1183","volume":"111","author":"XQ Li","year":"2004","unstructured":"Li XQ et al (2004) Interleukin-1 gene cluster polymorphisms and risk of Alzheimer\u2019s disease in Chinese Han population. J Neural Transm 111(9):1183\u20131190","journal-title":"J Neural Transm"},{"issue":"3","key":"9299_CR18","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1531-8249(200009)48:3<388::AID-ANA16>3.0.CO;2-G","volume":"48","author":"F Licastro","year":"2000","unstructured":"Licastro F et al (2000) Gene polymorphism affecting 1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer\u2019s disease risk. Ann Neurol 48(3):388\u2013391","journal-title":"Ann Neurol"},{"issue":"2","key":"9299_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/art.1780380210","volume":"38","author":"TL McDowell","year":"1995","unstructured":"McDowell TL et al (1995) A genetic association between juvenile rheumatoid arthritis and a novel interleukin-1 alpha polymorphism. Arthritis Rheum 38(2):221\u2013228","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9299_CR20","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0197-4580(01)00287-1","volume":"22","author":"RE Mrak","year":"2001","unstructured":"Mrak RE, Griffin WS (2001) Interleukin-1, neuroinflammation, and Alzheimer\u2019s disease. Neurobiol Aging 22(6):903\u2013908","journal-title":"Neurobiol Aging"},{"issue":"11","key":"9299_CR21","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1212\/WNL.56.11.1595","volume":"56","author":"GM Murphy Jr","year":"2001","unstructured":"Murphy GM Jr et al (2001) Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele. Neurology 56(11):1595\u20131597","journal-title":"Neurology"},{"issue":"3","key":"9299_CR22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G","volume":"47","author":"JA Nicoll","year":"2000","unstructured":"Nicoll JA et al (2000) Association of interleukin-1 gene polymorphisms with Alzheimer\u2019s disease. Ann Neurol 47(3):365\u2013368","journal-title":"Ann Neurol"},{"issue":"3","key":"9299_CR23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0306-4522(94)00596-W","volume":"66","author":"TG Ohm","year":"1995","unstructured":"Ohm TG et al (1995) Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation. Neuroscience 66(3):583\u2013587","journal-title":"Neuroscience"},{"issue":"1","key":"9299_CR24","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1086\/510686","volume":"80","author":"JV Pearson","year":"2007","unstructured":"Pearson JV et al (2007) Identification of the genetic basis for complex disorders by use of pooling-based genomewide single-nucleotide-polymorphism association studies. Am J Hum Genet 80(1):126\u2013139","journal-title":"Am J Hum Genet"},{"issue":"4","key":"9299_CR25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1212\/WNL.55.4.464","volume":"55","author":"J Rogers","year":"2000","unstructured":"Rogers J (2000) An IL-1-alpha susceptibility polymorphism in Alzheimer\u2019s disease: new fuel for the inflammation hypothesis. Neurology 55(4):464\u2013465","journal-title":"Neurology"},{"issue":"12","key":"9299_CR26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0166-2236(00)01661-1","volume":"23","author":"NJ Rothwell","year":"2000","unstructured":"Rothwell NJ, Luheshi GN (2000) Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 23(12):618\u2013625","journal-title":"Trends Neurosci"},{"key":"9299_CR27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-8-9","volume":"8","author":"SB Sando","year":"2008","unstructured":"Sando SB et al (2008) APOE epsilon4 lowers age at onset and is a high risk factor for Alzheimer\u2019s disease; a case control study from central Norway. BMC Neuro 8:9","journal-title":"BMC Neuro"},{"issue":"8","key":"9299_CR28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM et al (1993) Association of apolipoprotein E allele \u03b54 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology 43(8):1467\u20131472","journal-title":"Neurology"},{"issue":"3","key":"9299_CR29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1212\/WNL.48.3.626","volume":"48","author":"WF Stewart","year":"1997","unstructured":"Stewart WF et al (1997) Risk of Alzheimer\u2019s disease and duration of NSAID use. Neurology 48(3):626\u2013632","journal-title":"Neurology"},{"issue":"2","key":"9299_CR30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0304-3940(03)00333-1","volume":"343","author":"SJ Tsai","year":"2003","unstructured":"Tsai SJ et al (2003) Lack of association between the interleukin-1alpha gene C(-889)T polymorphism and Alzheimer\u2019s disease in a Chinese population. Neurosci Lett 343(2):93\u201396","journal-title":"Neurosci Lett"},{"issue":"2","key":"9299_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000104829","volume":"24","author":"HK Wang","year":"2007","unstructured":"Wang HK et al (2007) Interleukin-1alpha and -1beta promoter polymorphisms in Taiwanese patients with dementia. Dement Geriatr Cogn Disord 24(2):104\u2013110","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"9299_CR32","first-page":"186","volume":"28","author":"YT Zhou","year":"2006","unstructured":"Zhou YT et al (2006) Association between interleukin-1 alpha-889 C\/T polymorphism and Alzheimer\u2019s disease in Chinese Han population. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 28(2):186\u2013190","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"}],"container-title":["Cellular and Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-008-9299-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10571-008-9299-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10571-008-9299-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T18:06:32Z","timestamp":1559239592000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10571-008-9299-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,15]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["9299"],"URL":"https:\/\/doi.org\/10.1007\/s10571-008-9299-5","relation":{},"ISSN":["0272-4340","1573-6830"],"issn-type":[{"value":"0272-4340","type":"print"},{"value":"1573-6830","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,15]]}}}